TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways
Science Advances · 07.03.2025 · 11 (10)
DOI: 10.1126/sciadv.adq1047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.03.2025. Verfasst von Fabian A Fischer und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases, NLR Family, Pyrin Domain-Containing 3 Protein, I-kappa B Kinase. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The loss of TBK1, or both TBK1 and the related kinase IKKε, results in uncontrolled cell death–driven inflammation. Here, we show that the pathway leading to cell death depends on the nature of the activating signal. Previous models suggest that in steady state, TBK1/IKKε-deficient cells die slowly and spontaneously predominantly by uncontrolled tumor necrosis factor–RIPK1–driven death. However, upon infection of cells that express the NLRP3 inflammasome, (e.g., macrophages), with pathogens that activate this pathway (e.g., Listeria monocytogenes ), TBK1/IKKε-deficient cells die rapidly, prematurely, and exclusively by enhanced NLRP3-driven pyroptosis. Even infection with the RIPK1-activating pathogen, Yersinia pseudotuberculosis , results in enhanced RIPK1–caspase-8 activation and enhanced secondary NLRP3 activation. Mechanistically, TBK1/IKKε control endosomal traffic, and their loss disrupts endosomal homeostasis, thereby signaling cell stress. This results in premature NLRP3 activation even upon sensing “signal 2” alone, without the obligatory “signal 1.” Collectively, TBK1/IKKε emerge as a central brake in limiting death-induced inflammation by both RIPK1 and NLRP3 death-inducing pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
- Immunology Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Fabian A Fischer, Benjamin Demarco, Felicia Chan Hui Min, Hui Wen Yeap, Dominic De Nardo, Kaiwen W Chen, Jelena S Bezbradica
Zitieren
APA
Fischer, F. A., Demarco, B., Min, F. C. H., Yeap, H. W., De Nardo, D., Chen, K. W., & Bezbradica, J. S. (2025). TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways. Science Advances, 11(10). https://doi.org/10.1126/sciadv.adq1047
Vancouver
Fischer FA, Demarco B, Min FCH, Yeap HW, De Nardo D, Chen KW, et al. TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways. Science Advances. 2025;11(10). doi:10.1126/sciadv.adq1047
BibTeX
@article{Fischer2025,
author = {Fischer, Fabian A and Demarco, Benjamin and Min, Felicia Chan Hui and Yeap, Hui Wen and De Nardo, Dominic and Chen, Kaiwen W and Bezbradica, Jelena S},
title = {TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {10},
doi = {10.1126/sciadv.adq1047}
}
EUVIMED